Ruipeng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruipeng Wang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Jinfeng Qi
Department of Gastroenterology, The Second Qilu Hospital of Shandong University, Jinan 250033, China
1 shared publication- Junliang Li
Gansu University of Chinese Medicine Lanzhou China
1 shared publication - Junliang Li
The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou 730030, China; Department of General Surgery, Gansu Provincial Hospital, Lanzhou 730030, China; The First School of Clinical Medicine, Lanzhou University, Lanzhou 730030, China
1 shared publication - Tiankang Guo
The First School of Clinical Medicine of Lanzhou University, Lanzhou, China
1 shared publication Yuanyuan Deng
Department of Intensive Care Unit, The First Hospital of Lanzhou University, Lanzhou 730030, China
1 shared publication
Latest Publications
- 16 September 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 275, 156225
Apoptosis, ferroptosis, and the autophagy paradox in peritoneal metastasis
- 16 September 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 275, 156225
Apoptosis, ferroptosis, and the autophagy paradox in peritoneal metastasis
- Open Access
- 17 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (10) , 1498
Mechanisms of Peritoneal Mesothelial Cells in Peritoneal Adhesion
A peritoneal adhesion (PA) is a fibrotic tissue connecting the abdominal or visceral organs to the peritoneum. The formation of PAs can induce a variety of clinical diseases. However, there is currently no effective strategy for the prevention and treatment of PAs. Damage to peritoneal mesothelial cells (PMCs) is believed to cause PAs by promoting inflammation, fibrin deposition, and fibrosis formation. In the early stages of PA formation, PMCs undergo mesothelial–mesenchymal transition and have the ability to produce an extracellular matrix. The PMCs may transdifferentiate into myofibroblasts and accelerate the formation of PAs. Therefore, the aim of this review was to understand the mechanism of action of PMCs in PAs, and to offer a theoretical foundation for the treatment and prevention of PAs.
- 17 October 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (10) , 1498
Open AccessMechanisms of Peritoneal Mesothelial Cells in Peritoneal Adhesion
A peritoneal adhesion (PA) is a fibrotic tissue connecting the abdominal or visceral organs to the peritoneum. The formation of PAs can induce a variety of clinical diseases. However, there is currently no effective strategy for the prevention and treatment of PAs. Damage to peritoneal mesothelial cells (PMCs) is believed to cause PAs by promoting inflammation, fibrin deposition, and fibrosis formation. In the early stages of PA formation, PMCs undergo mesothelial–mesenchymal transition and have the ability to produce an extracellular matrix. The PMCs may transdifferentiate into myofibroblasts and accelerate the formation of PAs. Therefore, the aim of this review was to understand the mechanism of action of PMCs in PAs, and to offer a theoretical foundation for the treatment and prevention of PAs.